Angelo Márcio Leite Denadai

Title: Innovations of Angelo Márcio Leite Denadai

Introduction

Angelo Márcio Leite Denadai is a notable inventor based in Belo Horizonte, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that target cardiovascular diseases. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving health outcomes.

Latest Patents

Denadai holds a patent for a "Process for the preparation of compositions of AT1 receptor antagonist and Angiotensin-(1-7)." This patent describes the preparation of compounds that include AT1 receptor antagonists and Angiotensin (1-7), such as Angiotensin-(1-7) losartanate and its analogues. The patent outlines the use of cyclodextrins and their derivatives for micro-encapsulation of these compounds, which can be utilized in controlled or sustained release devices. The applications of these compounds extend to treating or preventing hypertension, cardiovascular diseases, and other related health issues.

Career Highlights

Denadai is affiliated with the Universidade Federal de Minas Gerais, where he continues to engage in research and development. His work is characterized by a strong focus on innovative solutions for complex health challenges. His contributions to the field have been recognized through his patent and ongoing research efforts.

Collaborations

Denadai has collaborated with notable colleagues, including Rubén Dario Sinisterra Millán and Cynthia Fernandes Ferreira Santos. These collaborations have enriched his research and expanded the impact of his innovations in the pharmaceutical field.

Conclusion

Angelo Márcio Leite Denadai is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact the treatment of cardiovascular diseases. His innovative approaches and collaborations highlight the importance of research in advancing healthcare solutions.